| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |